NCT02169804View on ClinicalTrials.gov

An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Pharmacokinetics
Interventions
DRUG

Androxal 25 mg

Trial Locations (1)

Unknown

Miami

All Listed Sponsors
lead

Repros Therapeutics Inc.

INDUSTRY

NCT02169804 - An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal | Biotech Hunter | Biotech Hunter